Showing 1 - 2 results of 2 for search 'C. Grandclement', query time: 0.03s Refine Results
  1. 1
    P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES

    P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES by C. Grandclement, C. Estoppey, E. Dheilly, M. Panagopoulou, E. Martini, V. Labanca, S. De Angelis, J. Frei, A. Drake, A. Rubod, G. Gudi, V. Udupa, J. Koch Olsen, R. Giovannini, M. A. Doucey, E. Feldman, C. Konto, A. Srivastava, M. Perro, S. Sammicheli

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma

    Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma by C. Grandclément, C. Estoppey, E. Dheilly, M. Panagopoulou, T. Monney, C. Dreyfus, J. Loyau, V. Labanca, A. Drake, S. De Angelis, A. Rubod, J. Frei, L. N. Caro, S. Blein, E. Martini, M. Chimen, T. Matthes, Z. Kaya, C. M. Edwards, J. R. Edwards, E. Menoret, C. Kervoelen, C. Pellat-Deceunynck, P. Moreau, M. L. Mbow, A. Srivastava, M. R. Dyson, E. A. Zhukovsky, M. Perro, S. Sammicheli

    Published 2024-03-01
    Get full text
    Article

Search Tools: